Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice (Q41342348)

29 September 2017

Cytomegalovirus prevention strategies in seropositive kidney transplant recipients: an insight into current clinical practice (English)

1 reference

29 September 2017

Mario Fernández-Ruiz

1

1 reference

29 September 2017

Manuel Arias

2

1 reference

29 September 2017

Josep M Campistol

3

1 reference

29 September 2017

David Navarro

4

1 reference

29 September 2017

Ernesto Gómez-Huertas

5

1 reference

29 September 2017

Gonzalo Gómez-Márquez

6

1 reference

29 September 2017

Juan Manuel Díaz

7

1 reference

29 September 2017

Domingo Hernández

8

1 reference

29 September 2017

Gabriel Bernal-Blanco

9

1 reference

29 September 2017

Frederic Cofan

10

1 reference

29 September 2017

Luisa Jimeno

11

1 reference

29 September 2017

Antonio Franco-Esteve

12

1 reference

29 September 2017

Esther González

13

1 reference

29 September 2017

Francesc J Moreso

14

1 reference

29 September 2017

Carlos Gómez-Alamillo

15

1 reference

29 September 2017

Alicia Mendiluce

16

1 reference

29 September 2017

Enrique Luna-Huerta

17

1 reference

29 September 2017

José María Aguado

18

1 reference

29 September 2017

OPERA Study Group

19

1 reference

29 September 2017

23 April 2015

1 reference

29 September 2017

Transplant International

1 reference

29 September 2017

28

1 reference

29 September 2017

9

1 reference

29 September 2017

1042-1054

1 reference

The 'indirect' effects of cytomegalovirus infection

29 September 2017

1 reference

Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988-2004.

21 January 2018

1 reference

Is there a change in cytomegalovirus seroepidemiology in Spain?

21 January 2018

1 reference

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

21 January 2018

1 reference

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

21 January 2018

1 reference

Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial

21 January 2018

1 reference

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

21 January 2018

1 reference

GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant patients.

21 January 2018

1 reference

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

21 January 2018

1 reference

International survey of cytomegalovirus management in solid organ transplantation after the publication of consensus guidelines.

21 January 2018

1 reference

Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease

21 January 2018

1 reference

American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation

21 January 2018

1 reference

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies

21 January 2018

1 reference

Universal prophylaxis is cost effective in cytomegalovirus serology-positive kidney transplant patients

21 January 2018

1 reference

Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy

21 January 2018

1 reference

Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience

21 January 2018

1 reference

Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival

21 January 2018

1 reference

Cytomegalovirus infection in renal transplant recipients.

21 January 2018

1 reference

Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.

21 January 2018

1 reference

Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation.

21 January 2018

1 reference

Evaluation of Low- Versus High-dose Valganciclovir for Prevention of Cytomegalovirus Disease in High-risk Renal Transplant Recipients

21 January 2018

1 reference

Increased risk of breakthrough infection among cytomegalovirus donor-positive/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis

21 January 2018

1 reference

Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation

21 January 2018

1 reference

Interlaboratory comparison of cytomegalovirus viral load assays.

21 January 2018

1 reference

An international multicenter performance analysis of cytomegalovirus load tests

21 January 2018

1 reference

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

21 January 2018

1 reference

Absence of cytomegalovirus-resistance mutations after valganciclovir prophylaxis, in a prospective multicenter study of solid-organ transplant recipients

21 January 2018

1 reference

Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis

21 January 2018

1 reference

A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant

21 January 2018

1 reference

Risk factors for late-onset cytomegalovirus infection or disease in kidney transplant recipients

21 January 2018

1 reference

Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study

21 January 2018

1 reference

Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report

21 January 2018

1 reference

Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): experience from the RESITRA-REIPI cohort.

21 January 2018

1 reference

Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment

21 January 2018

1 reference

Cytomegalovirus-infected human endothelial cells can stimulate allogeneic CD4+ memory T cells by releasing antigenic exosomes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRI.12586

1 reference

29 September 2017

1 reference